European regulators have accepted an application from Paratek Pharmaceuticals seeking approval of the broad-spectrum antibiotic omadacycline for two types of infection. More: EU accepts marketing application for Paratek’s antibiotic Source: News
read moreThe European Medicines Agency has granted Orchard Therapeutics’ experimental gene therapy OTL-300 PRIME designation as a potential treatment for the most severe form of beta-thalassemia. More: PRIME status for Orchard’s gene therapy Source: News
read moreJapanese scientist Tasuku Honjo wins Nobel Prize in medicine for PD-1 research; GenScript calls claims that its Johnson & Johnson-partnered Legend Biotech unit forged key CAR-T data “blatant slander”; some disgruntled Takeda shareholders demand details on the Shire buyout. More:
read moreRoche’s Hemlibra, already one of the company’s biggest-ever launches, officially has the new hemophilia indication it’s been waiting for—and that its competitors have been dreading. More: Roche’s fast-moving Hemlibra breaks into wider hemophilia market with blockbuster approval Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals